Live Analyst Rating Changes 28472 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ana Escalante
MS

Ana Escalante

Morgan Stanley
Wall Street Analyst
★★★☆☆
#2169
on 13Foresight · ranked by our own returns
47%
Success Rate
+0.9%
Average Return
7 of 15 calls profitable · -7.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 47% of Ana Escalante's ratings turned a profit when each position was held for 1 year — averaging +0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

15 Buy 6 Hold 13 Sell
Ana's Stock Coverage 13 ratings · 2026-08-29
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SSSAF
Shurgard Self Storage Limited
 Aug 14, 2026 HOLD Buy
+32.4% avg upside
7 analysts
$33.84
22.83% Upside
 -3.5% ·
GB:UTG
Unite Group plc
 Aug 04, 2026 BUY Strong Buy
+33.4% avg upside
12 analysts
$600.00
17.43% Upside
 -5.5% ·
ES:MRL
MERLIN Properties SOCIMI SA
 Jul 29, 2026 BUY Strong Buy
+6.6% avg upside
16 analysts
$17.50
29.60% Upside
 -8.9% ·
GB:SAFE
Safestore Holdings
 Jun 15, 2026 SELL Buy
+662.3% avg upside
9 analysts
$650.00
10.22% Upside
 +3.2% ·
GB:LMP
LondonMetric Property
 Jun 10, 2026 SELL Buy
+15.5% avg upside
11 analysts
$195.00
3.62% Upside
 -4.6% ·
GB:BYG
Big Yellow Group
 May 28, 2026 SELL Buy
+26.4% avg upside
13 analysts
$950.00
8.42% Upside
 -5.8% ·
CH:SPSN
Swiss Prime Site AG
 Mar 16, 2026 SELL Hold
-18.7% avg upside
6 analysts
$105.00
17.08% Downside
 +7.2% ·
FR:GFC
Gecina
 Mar 16, 2026 SELL Strong Buy
+64.2% avg upside
17 analysts
$80.00
14.66% Upside
 -3.6% ·
ES:COL
Inmobiliaria Colonial
 Mar 16, 2026 BUY Hold
+12.8% avg upside
11 analysts
$6.50
21.23% Upside
 +9.2% ·
GB:0MU2
Warehouses De Pauw SCA
 Mar 16, 2026 HOLD Buy
+20.7% avg upside
9 analysts
$27.00
26.75% Upside
 · ·
GB:0RD8
Xior Student Housing N.V.
 Mar 16, 2026 BUY Strong Buy
+32.0% avg upside
4 analysts
$38.00
40.77% Upside
 · ·
FR:ICAD
Icade SA
 Feb 23, 2026 HOLD Buy
+135.1% avg upside
15 analysts
$25.00
35.81% Upside
 -2.3% ·
FR:COV
Covivio SA
 Sep 01, 2025 SELL Buy
+31.9% avg upside
11 analysts
$60.00
19.54% Upside
 +1.2% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ana Escalante — Frequently Asked Questions
How accurate are Ana Escalante's stock ratings?
Based on the calls 13Foresight could measure, about 40% of Ana's ratings were profitable over a one-year hold, with an average return of +0.8% per rating, or -7.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ana ranked on 13Foresight?
Ana Escalante is currently ranked #2169 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ana cover?
Ana most recently has ratings on SSSAF, GB:UTG, ES:MRL, GB:SAFE, GB:LMP, GB:BYG, CH:SPSN, FR:GFC, ES:COL, GB:0MU2, GB:0RD8, FR:ICAD and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.